Neoantigen responses, immune correlates, and favorable outcomes after ipilimumab treatment of patients with prostate cancer

Research output: Contribution to journalArticlepeer-review

102 Scopus citations

Fingerprint

Dive into the research topics of 'Neoantigen responses, immune correlates, and favorable outcomes after ipilimumab treatment of patients with prostate cancer'. Together they form a unique fingerprint.

Medicine & Life Sciences